THE TREND
(Boursier.com) — The CAC 40 recorded 9 sessions of increases out of the first 11 of 2023 to post a gain of nearly 9% now! Rising to 7,052.52 points yesterday in session, the Parisian index will continue above 7,000 points this morning. However, the direction of the index is quite undecided thirty minutes before the start of the session according to the ‘futures’.
Investors have tasted a Chinese gross domestic product which grew by 2.9% year on year over the last three months of 2022, according to official statistics, which bring growth to 3.0% for the whole of the country. last year, a figure well below the Beijing target of around 5.5% and which marks one of the lowest growth rates since 1976!
At the same time, Chinese industrial production was up 1.3% year on year in December, after +2.2% a month earlier, and the decline in retail sales slowed more than expected, to 1. 8%. Finally, the first decline in population since 1961 also increases market concerns.
WALL STREET
Closed Monday.
ECO AND CURRENCIES
UNITED STATES :
– New York Fed Empire State Manufacturing Index. (2:30 p.m.)
Europe:
– Final German consumer price index. (08:00)
– UK employment figures. (08:00)
– Final Italian consumer price index. (11:00)
– German ZEW Economic Sentiment Index. (11:05 a.m.)
– European ZEW index of economic sentiment. (11:05 a.m.)
The euro/dollar parity reached $1.0838 this morning. A barrel of Brent is trading at $83.86. An ounce of gold is traded at $1,896.
VALUES TO FOLLOW
Guerbet plans to gradually withdraw from its micro-catheter activities historically housed within Accurate Medical Therapeutics. Since its takeover in 2018, the portfolio of micro-catheters has been very significantly expanded with today 38 references on the 2 ranges of SeQure and DraKon micro-catheters, intended for peripheral embolization procedures. An activity of little significance on a Group scale, it now requires specialized and strengthened sales teams and still significant investments to realize its full commercial potential, elements that no longer correspond to the Group’s development strategy. Guerbet also plans to sell the Occlugel technology acquired in 2018, comprising several ranges of microspheres for use in embolization.
Euronext announces that Euronext Clearing’s European expansion into Euronext’s derivatives markets is scheduled for Q3 2024. As of April 2021, Euronext owns Euronext Clearing (formerly CC&G), and is able to directly manage its business compensation to complete its value chain. In November 2021, Euronext announced its ambition to internalize the activity of clearing its cash flows and derivatives, currently operated by third-party service providers. As a result, Euronext Clearing will become the clearing house (CCP) of choice for cash equities, listed derivatives markets and commodities. As announced on November 3, 2022, Euronext confirms the first phase of Euronext Clearing’s expansion with the expected positioning of Euronext Clearing as Euronext’s central counterparty for its cash equity markets by the end of Q4 2023. Euronext will continue to offer an open access central counterparty model for capital clearing.
Gaussin achieved consolidated revenue (excluding licenses) of 57 million euros during the 2022 financial year, an increase of 39% compared to 2021. Revenue from licenses amounted to 0.3 ME . Total revenue from the activity thus amounts to 57.3 M€ in 2022 (52.8 MEUR in 2021), i.e. revenue growth of +8.6% in 2022.
ADP Group welcomed 280.4 million passengers across its airport network, including 86.7 million passengers at Paris Aéroport, i.e. a traffic recovery rate compared to 2019 in line with forecasts, at respectively 80 .9% for the group and 80.2% for Paris Aéroport.
Catana Group posted in the first quarter of its 2022-2023 financial year a turnover of 40.1 million euros, up 35% over one year.
LATEST REVENUES/RESULTS PUBLICATIONS…
Theraclion, genOway
THE LATEST “RECOS” FROM ANALYSTS…
Jefferies is buying on Paris airports with an adjusted objective of 142 to 155 euros and the purchase on Axa with a target raised from 32 to 34 euros.
Barclays is ‘overweight’ on STM targeting a course of 60 euros.
MARKET INFORMATION
Arkema placed a bond issue of 400 ME.
Deinove : the title will remain suspended until the decision of the TC of Montpellier on January 23.
namR launches a capital increase of 4.6 ME.
Theradiag : successful takeover bid for Biosynex.
IN SHORT
Altareit disputes the compensation claims of Primonial shareholders.
Balyo selected by Danone.
Roctool : international partnership with Standex Engraving.
IIS confirms the acquisition of 100% of Metanext.
Argan regains an occupancy rate of 100%.
icape withdraw from Russia.
Technip Energies : new contract with ADNOC in the United Arab Emirates.
Alstom wins a maintenance contract in Sweden.